Robert S. Wallis
0000-0001-6152-5183
Publication & Citation Trends
Publications
0 total
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trial.
Cited by 15
Semantic Scholar
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trial.
Cited by 14
Semantic Scholar
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TB
Cited by 3
Semantic Scholar
High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial OA
Cited by 70
Semantic Scholar
Research Topics
Tuberculosis Research and Epidemiology
(179)
Mycobacterium research and diagnosis
(91)
Infectious Diseases and Tuberculosis
(48)
Pneumocystis jirovecii pneumonia detection and treatment
(45)
Diagnosis and treatment of tuberculosis
(40)
Affiliations
Rutgers, The State University of New Jersey
South African Medical Research Council
University of Southern California
Uppsala University
Pharmaceutical Product Development (United States)